Dextrose adverse event reports that FDA received

Name: Reaction terms in FDA adverse event reports that name Dextrose
Creator: Reported Reactions
License: https://creativecommons.org/publicdomain/zero/1.0/

Name type: Generic name
Also reported as: Dextrose Injection

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Drug reports received through 30 Jun 2026. Device reports have a separate cutoff, 30 Sep 2026. Why a report count is not a rate.

Reports on file

From January 2004 to June 2026, FDA received 3,806 adverse event reports that name Dextrose. In these reports the drug is a suspect or interacting product.

In the same period, 9,322 further reports name it only as a concomitant medicine. The counts on this page do not include these reports.

FDA received 572 reports in the 12 months to June 2026 and 564 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 572 (under 0.1%) name Dextrose. Reports from consumers or other non-health professionals were 5.9% of the reports that name Dextrose and 45.8% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.

There are many instances of duplicative reports and some reports do not contain all the necessary information.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Suspect product

FDA records each drug in a report as suspect, concomitant or interacting. This page counts the reports in which Dextrose is suspect or interacting. FDA says:

Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Since the last update

FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

The latest update of the FDA data, recorded on 28 Oct 2026, changed no count of this page.

In April to June 2026, FDA received 117 reports that name Dextrose.
In January to March 2026, FDA received 159.
In April to June 2025, FDA received 136.

April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.

All updates Feed of updates (RSS)

Reaction lookup

These are the reaction terms that the reports record, with the number of reports for each term. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 513 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for 3,742 of the 3,806 reports (98.3%).

The reports of the other years are not in the counts.

So a count in the table can be lower than the count of FDA.

Find a reaction term

The table shows the first 50 of 513 terms.

Reaction terms in the reports that name Dextrose, most reports first
Reaction term (MedDRA) and plain meaning	Reports	Share of the 3,806 reports
Drug ineffectivethe medicine did not work as expected	579	15.2%
Off label useused for a purpose or in a way not on the label	453	11.9%
Myelosuppression	432	11.4%
Nauseafeeling sick	397	10.4%
Vomitingbeing sick	388	10.2%
Maternal exposure during pregnancythe mother took the medicine during pregnancy	358	9.4%
Hyponatraemialow blood sodium	334	8.8%
Condition aggravatedthe condition being treated got worse	327	8.6%
Acute kidney injurysudden loss of kidney function	314	8.3%
Product use in unapproved indicationused for a purpose not on the label	309	8.1%
Sepsisa severe body-wide response to infection	302	7.9%
General physical health deteriorationgeneral decline in health	301	7.9%
Abdominal painstomach or belly pain	293	7.7%
Ascitesfluid in the abdomen	286	7.5%
Multiple organ dysfunction syndromeseveral organs failing	271	7.1%
Abdominal distensiona bloated abdomen	264	6.9%
Dyspnoeashortness of breath	263	6.9%
Constipation	262	6.9%
Cardiogenic shockshock from the heart failing to pump	258	6.8%
Stress	254	6.7%
Ventricular fibrillationa chaotic rhythm from the lower heart chambers	249	6.5%
Appendicitis	241	6.3%
Appendicolith	238	6.3%
Premature delivery	225	5.9%
Foetal exposure during pregnancythe unborn baby was exposed to the medicine	217	5.7%
Drug hypersensitivityan allergic-type reaction (the term names a medicine)	214	5.6%
Somnolencedrowsiness	209	5.5%
Premature babya baby born early	201	5.3%
Anaemialow red blood cells	192	5%
Pyrexiafever	191	5%
Chronic obstructive pulmonary diseaseCOPD, a long-term lung disease	183	4.8%
Blood phosphorus increased	181	4.8%
Swelling	178	4.7%
White blood cell count decreasedlow white cell count	176	4.6%
Drug intolerancethe medicine was not tolerated	174	4.6%
Dry mouth	172	4.5%
Myasthenia gravis	167	4.4%
Deaththe patient died; cause not stated by this term	166	4.4%
Incorrect route of product administrationthe product was given by the wrong route	164	4.3%
Diabetes mellitusdiabetes	159	4.2%
Pulmonary embolisma blood clot in the lung	158	4.2%
Intentional product misusedeliberate use not as intended	157	4.1%
Thrombosis	157	4.1%
Hypotensionlow blood pressure	153	4%
Bacterial infectiona bacterial infection	151	4%
Hypoglycaemialow blood sugar	151	4%
Neuralgia	151	4%
Hypophosphataemia	147	3.9%
Blood cholesterol increasedraised cholesterol	146	3.8%
Hyperphosphataemia	145	3.8%

Download all 513 terms of Dextrose (CSV)

The counts add to more than 3,806 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The CSV file has the same rows and the same limits. Its last row is a note that says so.

MedDRA term

The person who codes a report selects the preferred term that agrees best with the description of the reporter. The words under a term are the plain meaning that this site gives.

Not the label

The FDA-approved label of a product lists its adverse reactions. See the official pages at the end of this page.

Outcomes by year

The table gives the outcomes that the reporters gave, in the terms of FDA.

Outcomes in the reports that name Dextrose, by the year of the openFDA file that holds the report

The table continues to the right.

Year of the openFDA file	Reports	Serious	Death	Life-threatening	Hospitalization (initial or prolonged)	Disability or Permanent Damage	Congenital Anomaly/Birth Defect	Other Serious (Important Medical Events)	Not serious
2004	2	1	1	0	0	0	0	0	1
2005	3	3	0	0	1	0	0	2	0
2006	4	3	1	1	0	0	0	1	1
2007	8	6	2	2	3	0	0	0	2
2008	8	6	0	0	2	0	0	5	2
2009	9	7	0	1	3	1	0	5	2
2010	10	9	2	3	5	0	0	5	1
2011	6	6	0	2	5	1	0	2	0
2012	8	7	3	0	1	0	0	4	1
2013	30	25	7	2	2	1	0	15	5
2014	250	248	7	3	7	4	0	237	2
2015	21	11	1	0	3	0	0	7	10
2016	42	24	5	4	7	0	0	18	18
2017	57	33	5	11	7	0	0	25	24
2018	65	56	15	14	15	0	0	27	9
2019	57	43	4	19	28	2	0	27	14
2020	78	74	21	13	34	0	0	45	4
2021	260	239	53	28	118	9	0	136	21
2022	533	493	130	78	211	56	5	365	40
2023	769	735	181	138	373	85	3	574	34
2024	635	620	112	117	298	46	8	476	15
2025	610	598	111	98	317	65	31	493	12
2026	341	338	108	83	221	72	48	237	3

An outcome in a report is not proof that the drug was the cause. The reporter gives the outcome, and FDA does not verify it. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The six headings with the names of FDA are the outcome terms of FDA. A report can have more than one outcome. The columns Serious and Not serious are the two values of the openFDA field serious. For the value serious, openFDA gives this description:

The adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition
Source: openFDA, Drug adverse event fields (YAML reference). The site read the page on 2 Oct 2026.

The year is the year of the openFDA file that holds the latest version of the report. It is not always the year in which FDA first received the report. The chart of the next section uses the year of first receipt. The latest year is not complete.

Reports by year and month

Reports that name Dextrose, by the year in which FDA received them

The column of 2026 has an outline, because the year is not complete. It has the reports that FDA received through June 2026 only.

Show the figures of the chart as a table

Reports that name Dextrose, by the year in which FDA received them
Year	Reports
2004	2
2005	3
2006	3
2007	9
2008	8
2009	7
2010	12
2011	5
2012	9
2013	35
2014	245
2015	24
2016	51
2017	60
2018	83
2019	74
2020	105
2021	339
2022	495
2023	832
2024	578
2025	551
2026	276

Reports that name Dextrose, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Why a count moves

A count moves for many reasons. The guide gives FDA's words about them.

Patients and reporters

Age of the patient in the reports that name Dextrose
Age	Reports	Share
Under 2	101	2.7%
2 to 11	129	3.4%
12 to 17	70	1.8%
18 to 44	650	17.1%
45 to 64	783	20.6%
65 to 74	317	8.3%
75 and over	581	15.3%
Age not given	1,175	30.9%

Sex of the patient in the reports that name Dextrose
Sex	Reports	Share
Female	1,824	47.9%
Male	1,262	33.2%
Unknown or not given	720	18.9%

Type of reporter in the reports that name Dextrose
Reporter	Reports	Share
Physician	1,323	34.8%
Pharmacist	216	5.7%
Other health professional	1,935	50.8%
Lawyer	2	0.1%
Consumer or non-health professional	225	5.9%
Not given	105	2.8%

Age and sex are as the report gives them. The reporter is the primary source in the report. 20.7% of the reports give the United States as the country.

Reason for use

Reason for use (indication) that the reports of Dextrose record
Indication as recorded (MedDRA)	Reports	Share
Medication dilution	677	17.8%
Nutritional supplementation	232	6.1%
Hypoglycaemia	197	5.2%
Arteriogram coronary	177	4.7%
Parenteral nutrition	125	3.3%
Foetal exposure during pregnancy	101	2.7%

The reporter fills in the indication, and the field is often empty. Each share is of all 3,806 reports.

Drugs in the same reports

Other drugs that the reports of Dextrose name, in any role, in order of name
Drug	Reports that name the two
Acetaminophen	476
Allopurinol	384
Azithromycin	384
Betamethasone	558
Cyclophosphamide	689
Magnesium sulfate	425
Ondansetron	408
Potassium chloride	592
Sodium bicarbonate	426
Sodium chloride	1,314

The table has the 10 drug names that these reports name most. Two names in one report says only that the report recorded the two. It says nothing about the part of a product in the event.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pages near this one

Dextromethorphan/Quinidine next in the A to Z list
Dextrose Sodium Chloride next in the A to Z list
Dextromethorphan, guaifenesin next in the A to Z list
Dexycu next in the A to Z list
Dextromethorphan polistirex next in the A to Z list
Dhc Plus next in the A to Z list
Dextromethorphan hydrobromide,guaifenesin next in the A to Z list
Di-Antalvic next in the A to Z list
Dextromethorphan Hydrobromide Quinidine Sulfate next in the A to Z list
Diabeta next in the A to Z list
Dextromethorphan hydrobromide next in the A to Z list
Diacomit next in the A to Z list

These links are for navigation. No count selected them.

Official pages

DailyMed labels for DextroseThe labels (prescribing information) that have this name, at the National Library of Medicine.
MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Dextrose: adverse event reports that FDA received. https://reportedreactions.com/drug/dextrose/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

A report is in the count when it names Dextrose as a suspect or interacting product. The 9,322 reports that name it only as a concomitant medicine are not in the count. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Do these reports show that Dextrose was responsible for the reactions?

No. FDA says:

For any given report, there is no certainty that a suspected drug caused the event.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

A reaction can relate to the condition that the drug treats, to other medicines, or to something else.

Is this the list of reactions on the label of Dextrose?

No. It is a count of what people reported to FDA: 3,806 reports from January 2004 to June 2026. The FDA-approved label of a product lists its adverse reactions. The official pages at the end of this page link to the labels.

Who sent these reports?

Other health professional (50.8%), physician (34.8%) and consumer or non-health professional (5.9%). These are the types of reporter for the reports that name this drug.

If a manufacturer receives an adverse event report, it is normally required to send the report to FDA.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.

To the top of the page